Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 01:14 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
NCT02444728 · Chinese SLE Treatment And Research Group · PHASE3 · terminated · last registry update 2022-03-14 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Because of insufficient enrollement” | – | Registry record, Chinese SLE Treatment And Research Group |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against TLR7 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-03-01Also stopped (terminated): Centre Hospitalier Universitaire de Saint Etienne, Hydroxychloroquine + Placebo of Hydroxychloroquine (NCT04328285)
- 2023-02-28Results posted on the registry: Rutgers, The State University of New Jersey, Hydroxychloroquine Sulfate + Azithromycin + Hydroxychloroquine Sulfate (NCT04336332)
- 2023-02-28Also stopped (terminated): Rutgers, The State University of New Jersey, Hydroxychloroquine Sulfate + Azithromycin + Hydroxychloroquine Sulfate (NCT04336332)
- 2023-02-21Phase 3 first posted: Hippocration General Hospital, Hydroxychloroquine + Colchicine (NCT05737680)
- 2023-02-17Results posted on the registry: The University of Texas Medical Branch, Galveston, Hydroxychloroquine (NCT01573754)
- 2023-02-15Results posted on the registry: University of Utah, Hydroxychloroquine + Placebo oral tablet (NCT04342169)
- 2023-02-03Also stopped (withdrawn): ASST Fatebenefratelli Sacco, Sarilumab Prefilled Syringe (NCT04386239)
- 2023-01-10Phase 3 first posted: Peking Union Medical College Hospital, Hydroxychloroquine + Tacrolimus (NCT05678335)
- 2023-01-04Phase 3 first posted: Ain Shams University, Cilostazol 100 MG + conventional synthetic antirheumatic drugs (NCT05671497)
- 2022-12-23Also stopped (withdrawn): Medical College of Wisconsin, Abemaciclib + Hydroxychloroquine 200 mg (NCT04316169)
- 2022-11-07Also stopped (suspended): Azidus Brasil, Hydroxychloroquine Sulfate + Azithromycin Tablets (NCT04329572)
- 2022-11-04Also stopped (suspended): Azidus Brasil, Hydroxychloroquine Sulfate + Azithromycin Tablets (NCT04348474)
- 2022-10-26Results posted on the registry: Brigham and Women's Hospital, Methotrexate + Sulfasalazine (NCT02374021)
- 2022-10-20Results posted on the registry: Charles Drew University of Medicine and Science, Hydroxychloroquine + Pioglitazone (NCT02303405)
- 2022-10-20Also stopped (terminated): Charles Drew University of Medicine and Science, Hydroxychloroquine + Pioglitazone (NCT02303405)
- 2022-08-08Results posted on the registry: University of Washington, Ascorbic Acid + Hydroxychloroquine Sulfate (NCT04354428)
- 2022-08-08Also stopped (terminated): University of Washington, Ascorbic Acid + Hydroxychloroquine Sulfate (NCT04354428)
- 2022-08-03Also stopped (withdrawn): Baqiyatallah Medical Sciences University, Hydroxychloroquine + Mucodentol (NCT04466280)
- 2022-07-14Phase 3 first posted: University Hospital, Brest, Blood sample + Urine sample (NCT05458622)
- 2022-07-11Also stopped (terminated): University Hospital, Strasbourg, France, Hydroxychloroquine + Azithromycin (NCT04359953)
- 2022-06-21Also stopped (terminated): MedSIR, Tocilizumab + Pembrolizumab (MK-3475) (NCT04335305)
- 2022-06-21Results posted on the registry: Henry Ford Health System, Hydroxychloroquine - Daily Dosing + Hydroxychloroquine - Weekly Dosing (NCT04341441)
- 2022-06-21Also stopped (terminated): Henry Ford Health System, Hydroxychloroquine - Daily Dosing + Hydroxychloroquine - Weekly Dosing (NCT04341441)
- 2022-06-16Results posted on the registry: Rutgers, The State University of New Jersey, hydroxychloroquine (NCT00726596)
- 2022-05-27Also stopped (withdrawn): King Hussein Cancer Center, HCQ & AZ vs HCQ+SIR (NCT04374903)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision